Iran’s speaker presents two medicines to UAE president
During a meeting between Iran’s Speaker of Parliament Mohammad Baqer Qalibaf and the President of the United Arab Emirates Mohammed bin Zayed Al Nahyan, two types of Iranian medicines were presented as a symbol of Iran’s advancements in medical science.
One of these medications is the cellular drug Recallercell, developed by Iranian scientists, for treating the incurable disease Vitiligo. Iran ranks as the twelfth country globally in producing this cell-based medicine, according to IRNA.
The second drug presented was the seasonal influenza vaccine, which was introduced in Iran in 2020 through the efforts of Iranian scientists using recombinant technology. This high-tech vaccine represents the scientific prowess of the nation and is considered a strategic health commodity. Iran stands as the second-largest producer of this four-season influenza vaccine, following the United States.
Following the presentation of these medicines, which received a positive reception from the UAE president, he expressed his country’s intention to conduct the necessary investigations to invest in the production of these Iranian drugs in Abu Dhabi.
Given the nature of these knowledge-based medications, it is expected that their introduction to the UAE government will pave the way for joint investments in the production of these Iranian products within the region.